UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2022~~2023

☐ TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to _________

Commission File Number: 000-28675

SAXON CAPITAL GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware		94-3370795
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

PO Box 147165, Lakewood, Colorado		80214
(Address of Principal Executive Offices)		(Zip Code)

303-323-4896

(Registrant’s telephone number, including area code)

~~ATLAS TECHNOLOGY GROUP, INC.~~________________________________________________________________

(Former Name, former address and former fiscal year, if changed since last report)

Securities registered under Section 12(b) of the Exchange Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer, ” "non-accelerated filer ," “ smaller reporting company, ” and “ emerging growth company ” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	[_]	Accelerated filer	[_]
Non-accelerated filer	[X]	Smaller reporting company	[X]
		Emerging growth company	[X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ~~Yes ☒ No ☐~~

~~As of~~Yes ~~October~~☒ ~~28,~~No ~~2022, there were 5,850,705,874 shares of common stock, $0.0001 par value per share, outstanding.~~ ☐

As of May 15, 2023, there were 14,981,701,785 shares of common stock, $0.00001 par value per share, outstanding.

TABLE OF CONTENTS

		Page
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	1918
Item 4.	Controls and Procedures	1918
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	2120
Item 1A.	Risk Factors	2120
Item 2.	Unregistered Sale of Equity Securities and Use of Proceeds	2120
Item 3.	Defaults Upon Senior Securities	2120
Item 4.	Mine Safety Disclosures	2120
Item 5.	Other Information	2120
Item 6.	Exhibits	2120
SIGNATURES		2221

PART I

Item 1. Financial Statements.

SAXON CAPITAL GROUP, INC.
(FORMERLY ATLAS TECHNOLOGY GROUP, INC.)
CONDENSED BALANCE SHEETS
(Unaudited)
	MARCH 31,			DECEMBER 31,
	SEPTEMBER 30,			DECEMBER 31,
	2023 (unaudited)			2022 (audited)
	2022			2021
ASSETS
Current Assets
Cash and Cash Equivalents	$	—		$	—
Prepaid expenses		—			1,167
Total Current Assets		—			—
Total Current Assets		—			1,167
Total Assets	$	—		$	—
Total Assets	$	—		$	1,167
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current Liabilities
Accounts Payable	$	5,140		$	4,100
Accounts Payable and Accrued Expenses	$	4,210		$	5,885
Accruals - Related Parties		~~159~~189,000			~~114~~174,000
Note Payable - Related Party		5881,~~310~~951			3567,~~639~~997
Total Current Liabilities		~~222~~275,~~450~~161			~~153~~247,~~739~~882
Total Liabilities		~~222~~275,~~450~~161			~~153~~247,~~739~~882
Commitments and Contingencies (Note 7)
Shareholders' Deficit
Series A Preferred Stock, $0.00001 value, 1 share authorized, 1 share issued and outstanding		39,900			39,900
Preferred Stock, $0.00001 par value, 24,999,000 shares authorized, 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022.		—			—
Series B Preferred Stock, $0.00001 par value, 24,999,999 authorized, no shares issued or outstanding		—			—
Series A Preferred Stock, $0.00001 par value,1,000 shares authorized, 501 shares issued and outstanding as of March 31, 2023 and December 31, 2022		19,990			19,990
Common Stock, $0.00001 par value, 15,000,000,000 shares authorized, 5,850,705,874 shares issued and outstanding		58,507			58,507
Common Stock, $0.00001 par value, 15,000,000,000 shares authorized, 14,981,701,785 shares issued and outstanding as of March 31, 2023 and December 31, 2022		149,817			149,817
Additional Paid In Capital		30,707,342			30,707,342
Additional Paid in Capital		30,635,942			30,635,942
Retained Deficit		(31,028,199	)		(30,958,321	)
Accumulated Deficit		(31,080,910	)		(31,053,631	)
Total Shareholders' Deficit		(~~222~~275,~~450~~161	)		(~~152~~247,~~572~~882	)
Total Liabilities and Shareholders' Deficit	$	—		$	~~1,167~~—
The accompanying notes are an integral part of these condensed unaudited financial statements.

The accompanying notes are an integral part of these condensed unaudited financial statements.

Table of Contents

SAXON CAPITAL GROUP, INC.
(FORMERLY ATLAS TECHNOLOGY GROUP, INC.)
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
(UNAUDITED)
	FOR THE THREE MONTHS ENDED						~~FOR THE NINE MONTHS ENDED~~
	2022			2021			2022			2021
	2023			2022
REVENUE	$	—		$	—		$	—		$	—
OPERATING EXPENSES:
General and administrative expenses		26,403			28,966			69,877			90,066
General and Administrative Expenses		27,279			17,447
Gain on partial settlement of debt		—			—			—			(4,270	)
Total Operating Expenses		27,279			17,447
Total Operating Expenses		26,403			28,966			69,877			85,796
OPERATING LOSS		(27,279	)		(17,447	)
OPERATING LOSS		(26,403	)		(28,966	)		(69,877	)		(89,796	)
OTHER INCOME (EXPENSE)		—			—
OTHER INCOME (EXPENSE)		—			—			—			—
LOSS BEFORE TAXES		(27,279	)		(17,447	)
Total Other income (expense)		—			—			—			—
TAXES		—			—
LOSS BEFORE TAXES		(26,403	)		(28,966	)		(69,877	)		(85,796	)
NET LOSS	$	(27,279	)	$	(17,447	)
TAXES		—			—			—			—
Net Loss per Common Shares Outstanding – Basic and Diluted	$	(0.00	)	$	(0.00	)
NET LOSS	$	(26,403	)	$	(28,966	)	$	(69,877	)	$	(85,796	)
Weighted Average Common Shares Outstanding – Basic and Diluted		14,981,701,785			5,850,707,874
Net Loss per Common Shares Outstanding – Basic and Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
The accompanying notes are an integral part of these condensed unaudited financial statements.
Weighted Average Common Shares Outstanding – Basic and Diluted		5,850,707,874			5,850,707,874			5,850,707,874			5,850,707,874

The accompanying notes are an integral part of these condensed unaudited financial statements.

Table of Contents

SAXON CAPITAL GROUP, INC.
(FORMERLY ATLAS TECHNOLOGY GROUP, INC.)
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT
(Unaudited)
(UNAUDITED)
	Series A Preferred Shares						Common Shares				Additional Paid-In		(Accumulated
	Shares			Amount			Shares		Amount		Capital		Deficit)			Total
Balance at December 31, 2020		1			176,360			5,850,705,874	$	58,507	$	30,530,982	$	(30,847,319	)	$	(81,470	)
THREE MONTHS
Net loss for the quarter		—			—			—		—		—		(9,150	)		(9,150	)
Balance at December 31, 2022		501		$	19,990			14,981,701,785	$	149,817	$	30,635,942		$(31,053,631	)	$	(247,882	)
Balance at March 31, 2021		1			176,360			5,850,705,874	$	58,507	$	30,530,982	$	(30,856,469	)	$	(90,620	)
Net loss for the quarter		—			—			—		—		—		(27,279	)		(27,279	)
Net loss for the quarter		—			—			—		—		—		(47,680	)		(47,680	)
Balance at March 31, 2023		501		$	19,990			14,981,701,785	$	149,817	$	30,635,942	$	(31,080,910	)	$	(275,161	)
Balance at June 30, 2021		1			176,360			5,850,705,874	$	58,507	$	30,530,982	$	(30,904,149	)	$	(138,300	)
Balance at December 31, 2021		1,000	*	$	39,900			5,850,705,874	$	58,507	$	30,707,342	$	(30,958,321	)	$	(152,572	)
Net loss for the quarter		—			—			—		—		—		(28,966	)		(28,966	)
Cancellation of Series A Preferred Stock		(1	)		(176,360	)		—		—		176,360		—			—
Issuance of Series A Preferred Stock		1			39,900			—		—		—		—			39,900
Balance at September 30, 2021		1			39,900			5,850,705,874	$	58,507	$	30,707,342	$	(30,933,115	)	$	(127,366	)
Balance at December 31, 2021		1			39,900			5,850,705,874	$	58,507	$	30,707,342	$	(30,958,321	)	$	(152,572	)
Net loss for the quarter		—			—			—		—		—		(17,447	)		(17,447	)
Balance at March 31, 2022		1,000	*	$	39,900			5,850,705,874	$	58,507	$	30,707,342	$	(30,975,768	)	$	(170,019	)
Net loss for the quarter		—			—			—		—		—		(26,027	)		(26,027	)
* As retrospectively restated for the 1:1,000 forward split completed effective November 25, 2022.
Balance at June 30, 2022		1			39,900			5,850,705,874	$	58,507		30,707,342		(31,001,795	)		(196,046	)
The accompanying notes are an integral part of these condensed unaudited financial statements.
Net loss for the quarter		—			—			—		—		—		(26,404	)		(26,404	)
Balance at September 30, 2022		1			39,900			5,850,705,874	$	58,507	$	30,707,342	$	(31,028,199	)	$	(222,450	)

The accompanying notes are an integral part of these condensed unaudited financial statements.

Table of Contents

SAXON CAPITAL GROUP, INC.
(FORMERLY ATLAS TECHNOLOGY GROUP, INC.)
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
(UNAUDITED)
	FOR THE NINE-MONTHS ENDED
	FOR THE THREE MONTHS ENDED
	SEPTEMBER 30,
	MARCH 31,
	2022			2021
	2023			2022
Cash Flows from Operating Activities:
Net Loss	$	(6927,~~877~~279	)	$	(8517,~~796~~447	)
Adjustments to reconcile net loss to net cash from operating activities
Compensation paid in preferred stock		—			39,900
Gain on partial settlement of liabilities		—			(4,270	)
Changes in working capital items:
Prepaid expenses		1,167			(2,917	)
Prepaid Expenses		—			1,167
Accounts payable		1,040			(2,050	)
Accounts Payable and Accrued Expenses		(1,675	)		100
Accruals - related parties		45,000			27,000
Accruals - Related Parties		15,000			15,000
Net Cash Flows Used in Operating Activities		(2213,~~670~~954	)		(281,~~133~~180	)
Net Cash Flows Used in Investing Activities		—			—
Cash Flows from Financing Activities
Note Payable - Related Party		2213,~~670~~954			281,~~133~~180
Net Cash Flows From Financing Activities		2213,~~670~~954			281,~~133~~180
Net Cash Flows From Investing Activities		—			—
Net Change in Cash:		—			—
Beginning Cash:	$	—		$	—
Ending Cash :	$	—		$	—
Ending Cash:	$	—		$	—
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	$	—		$	—
Cash paid for tax	$	—		$	—
The accompanying notes are an integral part of these condensed unaudited financial statements.

The accompanying notes are an integral part of these condensed unaudited financial statements.

Table of Contents

SAXON CAPITAL GROUP, INC.

(FORMERLY ATLAS TECHNOLOGY GROUP, INC.)

NOTES TO CONDENSED UNAUDITED FINANCIAL STATEMENTS

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30~~MARCH 31, ~~2022~~2023

NOTE 1. NATURE OF OPERATIONS

Nature of Business

Saxon Capital Group Inc., formerly Atlas Technology Group Inc., is a SEC reporting shell company. Shares of our common stock can only be traded in the expert market as of the date of this report. We believe this is due to there being no broker dealers willing to quote our stock. We intend to seek approval for our shares of common stock to be traded on the Pink Sheets again. Once relisted on the Pink Sheets, we will then seek to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create ~~values~~value for our shareholders. There is no guarantee that we will be successful in becoming relisted on the Pink Sheets and no potential merger candidate has been identified at this time.

Saxon Capital Group Inc. (“the Company,” “We," "Us," or “Our’) was incorporated under the laws of State of Delaware as on July 12, 2022.

Atlas Technology Group, Inc., a Florida corporation, merged into Saxon Capital Group, Inc effective from August 30, 2022. Now the surviving entity is Saxon Capital Group, Inc.

Effective May 29, 2021, we entered into an agreement with Corporate Excellence Consulting Inc. (“CECI”), our then controlling shareholder, and Mr. David Cutler (“Mr. Cutler”) (“the Agreement”) under which:

	-	CECI surrendered, and we cancelled, the single outstanding share of Series A Preferred Stock. The single outstanding share of Series A Preferred Stock carried super preferred voting rights enabling the holder to vote the equivalent of 61% of all voteable preferred and common shares issued and outstanding,
	-	We issued a new share of Series A Preferred Stock, carrying the same super preferred voting rights described above, to Mr. Cutler. As a consequence of this issuance, Mr. Cutler became our new controlling shareholder,
	-	Mr. Cutler was appointed as a director of ours and as our Chief Financial Officer,
	-	Mr. Cutler paid $5,000 to CECI on our behalf as a partial repayment of the outstanding fees due by us to CECI,
	-	Mr. Cutler undertook to pay a further $30,000 on our behalf as a full and final settlement of the outstanding fees due by us to CECI, such payment to be made on the approval by FINRA of a proposed name change and reverse stock split,
	-	CECI agreed to accept the $35,000 to be paid to them by Mr. Cutler on our behalf in full and final settlement of the outstanding fees due by us to CECI.

The initial payment of $5,000 to CECI was made by Mr. Cutler as agreed.

There is no guarantee that it will be possible to complete the remaining terms of the Agreement.

Effective November 10, 2021, the Board of directors recommended, and the holder of a majority of the voting power of our outstanding common stock voted, to approve the following items:

a reverse split of the common stock issued and outstanding on a one new share for one million (1,000,000) old shares basis as of November 10, 2021. Fractional shares will be rounded up to the next whole share. (This action requires an amendment to the Certificate of Incorporation and requires the approval of the Financial Industry Regulatory Authority (“FINRA”)), and

- a forward split of the common stock issued and outstanding as of November 10, 2021. Subsequent to the 1/1,000,000 reverse split described above, each share of post reverse split adjusted issued and outstanding Common Stock shall be forward split on a one for one hundred (100) basis such that each post reverse split old share represents 100 new shares. Fractional shares will be rounded up to the next whole share.

Table of Contents

~~These~~- ~~proposed~~a ~~actions~~forward ~~are~~split ~~still~~of ~~pending FINRA~~the ~~approval~~common stock issued and outstanding as of November 10, 2021. Subsequent to the 1/1,000,000 reverse split described above, each share of post reverse split adjusted issued and outstanding Common Stock shall be forward split on a one for one hundred (100) basis such that each post reverse split old share represents 100 new shares. Fractional shares will be rounded up to the next whole share.

Effective November 17, 2022 Board of Director approved the following actions to:

Cancel all 24,999,999 shares of authorized but unissued shares of Series B Preferred Stock.

Increase the number of shares authorized Series A Preferred Stock from 1 to 1,000.

Forward split each share of issued and outstanding Series A Preferred Stock as of record date November 25, 2022 in the ratio of 1:1,000, such that each old share represents 1,000 new shares.

Convert 499 post-split shares of Series A Preferred Stock into 9,130,995,911 shares of our common stock leaving 501 shares of post-split Series A stock issued and outstanding.

History

Saxon Capital Inc. was incorporated in the state of Nevada in August 1996 under the name Pan World Corporation. In November 1999, the Company changed its name to Tribeworks, Inc. and redomiciled to the state of Delaware. In August 2007, the Company changed its name to Atlas Technology Group, Inc. In August 2015, the Company redomiciled to the State of Florida. In December 2015, the Company changed its name to Moxie Motion Pictures, Inc. In November 2018, the Company changed its name back to Atlas Technology Group, Inc. On August 30, 2022 Atlas Technology Group, Inc merged into Saxon Capital Group, Inc and redomiciled from State of Florida to State of Delaware. Now the surviving corporation is Saxon Capital Group, Inc.

Since its Inception in August 1996, the Company has at various times been involved in the following business activities: software sales, provision of information technology application support services, distribution of energy efficient lighting products and movie production and talent management.

By December 31, 2018, the Company had ceased all operations and had disposed of all its former operating subsidiaries.

Impact of the COVID-19 Pandemic

We have not commenced operations as yet and consequently have not been directly impacted by the Covid-19 outbreak at this time. However, the detrimental effect of the Covid-19 outbreak on the economy as a whole may have a detrimental impact on our ability to raise funding and identify an entity to merge with for the foreseeable future. We are unable to predict with any certainty the ultimate impact Covid-19 outbreak on our plans at this time.

Impact of the Ukrainian Conflict

We have not commenced operations as yet and consequently have not been directly impacted by the Ukrainian conflict at this time Currently, we do not believe that the conflict between Ukraine and Russia will have any direct impact on our operations, financial condition or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it is having a general impact on all business operations resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and domestic inflationary results of the conflict and government spending for and funding of their response. We do not believe we will be targeted for cyber-attacks. We have no operations in the countries directly involved in the conflict or that are specifically impacted by any of the sanctions and embargoes, we do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

NOTE 2. GOING CONCERN

Our financial statements are prepared using accounting principles generally accepted in the United States of America (“GAAP”) applicable to a going concern, which contemplate the realization of assets and the liquidation of liabilities in the normal course of business. We have no ongoing business or income and for the nine-months period ended September 30, 2022 we incurred a loss of $69,877 and had an accumulated deficit of $31,028,199 as of September 30, 2022. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. Our ability to continue as a going concern is dependent upon our ability to raise additional debt or equity funding to meet our ongoing operating expenses and ultimately in merging with another entity with experienced management and profitable operations. No assurances can be given that we will be successful in achieving these objectives.

Table of Contents

on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

NOTE 2. GOING CONCERN

Our financial statements are prepared using accounting principles generally accepted in the United States of America (“GAAP”) applicable to a going concern, which contemplate the realization of assets and the liquidation of liabilities in the normal course of business. We have no ongoing business or income and for the three-months period ended March 31, 2023 we incurred a loss of $27,279 and had an accumulated deficit of $31,080,910 as of March 31, 2023. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. Our ability to continue as a going concern is dependent upon our ability to raise additional debt or equity funding to meet our ongoing operating expenses and ultimately in merging with another entity with experienced management and profitable operations. No assurances can be given that we will be successful in achieving these objectives.

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The summary of significant accounting policies is presented to assist in the understanding of the financial statements. These policies conform to GAAP and have been consistently applied. The Company has selected December 31 as its financial year end.

Forward Stock Split

On November 17, 2022, the Company’s Board of Directors approved a forward stock split at in ratio of one-for-one thousand in respect of the Company’s series A Preferred Stock. Such forward stock split was implemented effective November 25, 2022 increasing the number of issued Series A Preferred Stock form 1 to 1,000. The par value for the Series A Preferred Stock was not affected.

All numbers of Series A Preferred Stock in these financial statements have been retroactively restated for the effect to the Forward Split for all periods presented

Interim Financial Statements

The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of ~~September~~March 3031, ~~2022~~2023 and for the related periods presented, have been included. The results for the three ~~and nine~~ months period ended ~~September~~March 3031, ~~2022~~2023 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the years ended December 31, ~~2021~~2022 ~~and 2020~~ included in our Form 10-K filed on ~~April~~February 1517, ~~2022~~2023.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Table of Contents

Cash and Cash Equivalents:

We maintain cash balances in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~ 2022, our cash balances were $0.

Fair Value Measurements:

ASC Topic 820, Fair Value Measurements and Disclosures ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.

Level 2 – Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.

Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.

Our financial instruments consist of our ~~prepaid expenses,~~ accounts payable, and accrued expenses, accruals - related parties and note payable – related party. The carrying amount of our accounts ~~prepaid~~payable and accrued expenses, ~~accounts~~accruals - related parties and note payable, ~~accrued~~– ~~expenses~~related party approximates their fair values because of the short-term maturities of these instruments.

Table of Contents

related parties and note payable – related party approximates their fair values because of the short-term maturities of these instruments.

Related Party Transactions:

A related party is generally defined as (i) any person that holds 10% or more of our membership interests including such person's immediate families, (ii) our management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with us, or (iv) anyone who can significantly influence our financial and operating decisions. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See Notes 5, 6 and 86 below for details of related party ~~transactions~~ transactions in the period presented.

Leases:

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the balance sheet.

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. We generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term.

The Company was not party to any lease transaction during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022.

Table of Contents

Income Taxes:

The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

Uncertain Tax Positions:

We evaluate tax positions in a two-step process. We first determine whether it is more likely than not that a tax position will be sustained upon examination, based on the technical merits of the position. If a tax position meets the more-likely-than-not recognition threshold, it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We classify gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as long-term liabilities in the financial statements.

Revenue Recognition:

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

Table of Contents

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when the entity satisfies a performance obligation

As the Company had no business operations during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, we have not identified specific planned revenue streams.

During the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, we did not recognize any revenue.

Advertising Costs:

We expense advertising costs when advertisements occur. No advertising costs were incurred during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022.

Stock-Based Compensation:

The cost of equity instruments issued to employees and non-employees in return for goods and services is measured by the grant date fair value of the equity instruments issued in accordance with ASC 718, Compensation – Stock Compensation. The related expense is recognized as services are rendered or vesting periods elapse.

Net Loss per Share Calculation:

Basic earnings (loss) per common share ("EPS") is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding, assuming all dilutive potential common shares were issued. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.

Table of Contents

Recently Accounting Pronouncements:

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

NOTE 4. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

As of ~~September~~March 3031, 2023 ~~2022~~ and December 31, ~~2021~~2022, the balance of accounts payable totaled $54,~~140~~210 and $45,~~100~~885, respectively. The balance owed as of March 31, 2023 was to the Company’s share transfer agent and in respect of Edgar filing fees. The balance owed as of December 31, 2022 was to the Company’s share transfer agent.

~~These~~NOTE ~~balances were~~5. ~~owed~~ACCRUALS to- ~~the~~RELATED ~~Company’s share transfer agent.~~PARTIES

~~NOTE~~As 5.of ~~ACCRUED~~March ~~EXPENSES~~31, 2023 and December 31, 2022, the balance of accruals - ~~RELATED~~related ~~PARTIES~~parties totaled $189,000 and $174,000, respectively.

AsThese ofaccruals ~~September~~relate 30to consulting fees due our current controlling shareholder, ~~2022~~director and ~~December~~chief ~~31,~~financial ~~2021~~officer ($110, ~~the~~000 ~~balance~~and of$95,000, ~~accruals~~respectively) -and ~~related~~our ~~parties~~former ~~totaled~~controlling shareholder ($~~159~~79,000 and $~~114~~79,000, respectively).

These accruals relate to consulting fees due our current controlling shareholder, director and chief financial officer ($80,000 and $35,000, respectively) and our former controlling shareholder ($79,000 and $79,000, respectively).

NOTE 6. NOTE PAYABLE – RELATED PARTY

As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the balance of notes payable – related party totaled $5881,~~310~~951 and $3567,~~639~~997, respectively.

9During the three-months period ended March 31, 2023, our new controlling shareholder, director and chief financial officer, advanced to us $13,954 (2022 - $1,180), by way of a promissory note to finance our working capital requirements.

Table of Contents

During the nine-months period ended September 30, 2022, our new controlling shareholder, director and chief financial officer, advanced to us $22,670 (2021 - $28,133), by way of a promissory note to finance our working capital requirements.

The promissory note is unsecured, due on demand and interest free.

NOTE 7. COMMITMENTS & CONTINGENCIES

Legal Proceedings

We were not subject to any legal proceedings during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 or ~~2021~~2022, and, to the best of our knowledge, no legal proceedings are pending or threatened.

Contractual Obligations

We are not party to any contractual obligations at this time.

NOTE 8. SHAREHOLDERS’ DEFICIT

Preferred Stock

We are authorized to issue 25,000,000 shares of preferred stock with a par value of $0.00001, with such relative rights, preferences and designations as may be determined by our Board of Directors in its sole discretion upon the issuance of any shares of Preferred Stock.

1 share of Series A Preferred Stock and 24,999,999 shares of Series B Preferred Stock were designated effective July 27, 2015.

~~There~~Effective ~~are~~November no17, ~~remaining~~2022 ~~shares~~Board of ~~preferred~~Director ~~stock~~approved ~~available~~the ~~for~~following ~~designation~~actions ~~at this time.~~to:

Cancel all 24,999,999 shares of authorized but unissued shares of Series B Preferred Stock.

Table of Contents

Increase the number of shares authorized Series A Preferred Stock from 1 to 1,000.

As on March 31, 2023, there are 24,999,000 shares of preferred stock available for designation.

Series A Preferred Stock

As of ~~September~~March 3031, ~~2022~~2023, we were authorized to to issue 1,000 share of Series A Preferred Stock with a par value of $0.00001.

1501 share of Series A Preferred Stock was issued and outstanding as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

The share of Series A Preferred Stock carried super majority voting rights such that it can vote the equivalent of 61% of all votable preferred and common stock at all times.

The share of Series A Preferred Stock was convertible into 1,000 shares of common stock at the option of the Holder.

As described above, effective May 29, 2021, the 1 existing issued share of Series A Preferred Stock was returned to us by of former controlling shareholder and cancelled by us.

Further on May 29, 2021, we issued a new share of Series A Preferred Stock, valued by an independent, third party valuation company at $39,900, as compensation to our new controlling shareholder, director and Chief Financial Officer.

~~The~~However, ~~new~~effective November 25, 2022, the single share of Series A Preferred Stock ~~carries the~~issued ~~same~~and ~~super~~outstanding ~~majority~~was ~~voting~~forward ~~rights~~split asin ~~before~~the ~~such~~ratio ~~that~~of it1:1,000, ~~can~~such ~~vote~~that the ~~equivalent~~single ofoutstanding old ~~61%~~share ofwas ~~all~~replaced ~~votable~~with ~~preferred~~1,000 ~~and~~new ~~common stock at all times~~shares.

~~However, the~~The ~~new~~single share of Series A Preferred Stock originally iscarried ~~now~~super ~~convertible~~majority ~~into~~ voting rights such ~~number~~that ofit ~~shares~~could ofvote ~~common~~the ~~equal~~equivalent to of 61% ~~ownership~~ of ~~the~~all ~~common~~votable ~~stock~~preferred ofand ~~the~~common stock ~~Company~~ at ~~the~~all ~~option of the Holder~~times.

Table of Contents

Subsequently the super majority voting power of the single share of Series A Preferred Stock was increased from 61% to 68%.

Following the 1 ~~share~~: 1,000 forward split effective November 25, 2022, each one of the 1,000 post forward split shares of Series A Preferred Stock ~~was~~is ~~issued~~now ~~and~~convertible ~~outstanding~~into 18,298,589 shares asof common stock with total voting rights equal to 76% ownership of ~~September~~the ~~30,~~common ~~2022~~stock of the Company at the option of the Holder.

Effective November 25, 2022, 499 shares of Series BA Preferred Stock was converted into 9,130,995,911 shares of common stock and remaining 501 shares are issued and outstanding as on March 31, 2023.

As of ~~September 30~~March, ~~2022,~~2023 weand ~~were~~December ~~authorized to~~31, ~~issue 24~~2022,~~999,999~~ 501 shares of Series BA Preferred Stock ~~with~~were aissued ~~par~~and ~~value~~outstanding ~~of $0~~respectively.~~00001.~~

Each share of Series B Preferred Stock is entitled to one vote.

In the event of a liquidation, each share of Series B Preferred Stock is entitled to $1.00 per share distribution before any distribution is made to holders of any stock ranking junior to the Series B Preferred Stock.

Each share of series B Preferred Stock is convertible into 100,000 common shares of the Company.

No shares of Series B Preferred Stock were issued or outstanding during the nine-months period ended September 30, 2022 and 2021.

Common Stock

As of ~~September~~March 3031, ~~2022~~2023, we were authorized to to issue 15,000,000,000 shares of common stock with a par value of $0.~~0001~~00001.

No shares of common stock were issued during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022 and 2021~~2023.

As Effective ofNovember ~~September~~10, 302021, ~~2022~~the Company’s controlling shareholder and ~~December~~the ~~31,~~Board ~~2021,~~approved a 51 for 1,~~850~~000,~~705,874~~000 reverse ~~shares~~share split, followed by a 100 for 1 forward share split. This change in the number of common ~~stock~~shares ~~were~~ issued and outstanding is pending FINRA approval.

Effective November 1025, ~~2021~~2022, ~~the~~499 ~~Board of directors~~Series ~~recommended,~~A ~~and~~Preferred ~~the~~Stock ~~holder~~was ofconverted ainto ~~majority~~9,130,995,911 ofshares ~~the voting power~~ of ~~our outstanding~~ common stock ~~voted, to approve the following items:~~.

- As ~~a reverse split~~ of ~~the~~March ~~common~~31, ~~stock~~2023 ~~issued~~ and ~~outstanding~~December ~~on a one new share for one million (1~~31,~~000~~ 2022,~~000) old shares basis as of November 10~~ 14,981,701,785 ~~2021. Fractional~~ shares ~~will be rounded up to the next whole share. (This action requires an amendment to the Certificate~~ of ~~Incorporation~~common ~~and~~stock ~~requires~~were ~~the~~issued ~~approval of the Financial Industry Regulatory Authority (“FINRA”)),~~ and outstanding.

~~These~~Table ~~proposed~~of ~~actions are still pending FINRA approval.~~Contents

Warrants

No warrants were issued or outstanding during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022 and 2021~~2023.

Stock Options

We currently have no stock option plan.

No stock options were issued or outstanding during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022.

Table of Contents

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events after ~~September~~March 3031, ~~2022~~2023, in accordance with FASB ASC 855 Subsequent Events, through the date of the issuance of these financial statements and has determined there have been no subsequent events for which disclosure is required.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

Certain statements made in this quarterly report on Form 10-Q are “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995) in regard to the plans and objectives of management for future operations. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the registrant to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. The Company’s plans and objectives are based, in part, on assumptions involving the continued expansion of business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes its assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance the forward-looking statements included in this quarterly report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the registrant or any other person that the objectives and plans of the registrant will be achieved.

Substantial risks exist with respect to an investment in the Company. These risks include but are not limited to, those factors discussed in our Annual Report on Form 10-K for the fiscal years ended December 31, ~~2021 and 2020~~2022, filed with the Securities and Exchange Commission (“Commission”) on ~~April~~February 1517, ~~2022~~2023. More broadly, these factors include, but are not limited to:

●

We have incurred significant losses and expect to incur future losses;

●

Our current financial condition and immediate need for capital;

●

Potential significant dilution resulting from the issuance of new securities for any funding, debt conversion

or any business combination; and

●

We are a “penny stock” company.

OVERVIEW

Saxon Capital Group, Inc., formerly Atlas Technology Group, Inc., a Delaware corporation, (“the Company”, “We", "Us" or “Our’) is a SEC reporting shell company. Shares of our common stock can only be traded in the expert market as of the date of this report. We believe this is due to there being no broker dealers willing to quote our stock. We intend to seek approval for our shares of common stock to be traded on the Pink Sheets again. Once relisted on the Pink Sheets, we will then seek to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create ~~values~~value for our shareholders. There is no guarantee that we will be successful in becoming relisted on the Pink Sheets and no potential merger candidate has been identified at this time.

Saxon Capital Group Inc. (“the Company,” “We," "Us," or “Our’) was incorporated under the laws of State of Delaware as on July 12, 2022.

Atlas Technology Group, Inc., a Florida corporation, merged into Saxon Capital Group, Inc effective from August 30, 2022. Now the surviving entity is Saxon Capital Group, Inc.

PLAN OF OPERATION

Our plan of operation is to obtain debt or equity finance to meet our ongoing operating expenses and attempt to relist our shares of common stock on the Pink Sheets and then merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that any of the events can be successfully completed, that our shares of common stock will be relisted on the Pink Sheets, any such business will be identified or that any stockholder will realize any return on their shares after such a transaction has been completed. In particular, there is no assurance that any such business will be located or that any stockholder will realize any return on their shares after such a transaction. Any merger or acquisition

Table of Contents

completed by us can be expected to have a significant dilutive effect on the percentage of shares held by our current stockholders

As of ~~September~~March 3031, ~~2022,~~ 2023, we had no cash on hand and committed resources of debt or equity to fund these losses. We will be reliant, potentially, on ~~advances~~ advances from our principal shareholders or our directors and officers. There can be no guarantee that we will be able to obtain ~~sufficient~~ sufficient funding these sources.

Our principal shareholder has indicated his intention to provide such funds as may be required for the Company to become, and remain, a fully reporting public company while seeking to create value for shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of its common stock. Such intentions do not represent a binding commitment by the principal shareholder and there is no guarantee that our two principal shareholders will be able to provide the funding necessary to achieve this objective.

We currently believe that our principal shareholder will be able to provide us with the funding necessary to effect our business plan to merge with another entity. However, while our principal shareholder has indicated his intention to provide us with sufficient funding to achieve this objective, there is no guarantee that he will be able to provide funding necessary to enable us to merge with another entity.

If we are unable to obtain the necessary funding from our principal shareholder, we anticipate facing major challenges in raising the necessary funding to effect our business plan to merge with another entity. Raising debt or equity funding for small publicly quoted, penny stock, shell companies is always extremely challenging.

We may face a number of obstacles in our attempt to raise funding to achieve our objective of merging with a yet to be identified company or group. One of those is Rule 419, under the Securities Act of 1933.

Rule 419 defines a "blank check company" as a company that: i. Is a development stage company that has no specific business plan or purpose or has indicated that its business plan is to engage in a merger or acquisition with an unidentified company or companies, or other entity or person; and ii. Is issuing "penny stock," as defined in Rule 3a51-1 under the Securities Exchange Act of 1934.

We are a “blank check company” and therefore, in order to raise public or private funds, we must comply with the requirements of Rule 419 which includes restrictive escrow and other provisions. These provisions will make it difficult, if not impossible, for us to raise funds for the company.

Therefore, because of these difficulties in raising funding in penny stock or shell companies, if our principal shareholder is unable to provide us with the funding required to merge with another entity, it is very likely that we will be unable to implement our business plan to merge with another entity to create value for all of our shareholders”.

We believe we are an insignificant participant among the firms which engage in the acquisition of business opportunities. There are many established venture capital and financial concerns that have significantly greater financial and personnel resources and technical expertise than we have. In view of our limited financial resources and limited management availability, we will continue to be at a significant competitive disadvantage compared to our competitors.

We intend to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to us by persons or firms which desire to seek the advantages of an issuer who has complied with the Securities Act of 1934 (the “1934 Act”). We will not restrict our search to any specific business, industry or geographical location, and we may participate in business ventures of virtually any nature. This discussion of our proposed business is purposefully general and is not meant to be restrictive of our virtually unlimited discretion to search for and enter into potential business opportunities. We anticipate that we may be able to participate in only one potential business venture because of our lack of financial resources.

We may seek a business opportunity with entities which have recently commenced operations, or that desire to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service, or for other corporate purposes. We may acquire assets and establish wholly owned subsidiaries in various businesses or acquire existing businesses as subsidiaries.

Table of Contents

We expect that the selection of a business opportunity will be complex and risky. Due to general economic conditions, rapid technological advances being made in some industries and shortages of available capital, we believe that there are numerous firms seeking the benefits of an issuer who has complied with the 1934 Act. Such benefits may include facilitating or improving the terms on which additional equity financing may be sought, providing liquidity for incentive stock options or similar benefits to key employees, providing liquidity (subject to restrictions of applicable statutes) for all stockholders and other factors. Potentially, available business opportunities may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. We have, and will continue to have, essentially no assets to provide the owners of business opportunities. However, we will be able to offer owners of acquisition candidates the opportunity to acquire a controlling ownership interest in an issuer who has complied with the 1934 Act without incurring the cost and time required to conduct an initial public offering.

The analysis of new business opportunities will be undertaken by, or under the supervision of, our sole director. We intend to concentrate on identifying preliminary prospective business opportunities which may be brought to our attention through present associations of our director, professional advisors or by our stockholders. In analyzing prospective business opportunities, we will consider such matters as (i) available technical, financial and managerial resources; (ii) working capital and other financial requirements; (iii) history of operations, if any, and prospects for the future; (iv) nature of present and expected competition; (v) quality, experience and depth of management services; (vi) potential for further research, development or exploration; (vii) specific risk factors not now foreseeable but that may be anticipated to impact the proposed activities of the company; (viii) potential for growth or expansion; (ix) potential for profit; (x) public recognition and acceptance of products, services or trades; (xi) name identification; and (xii) other factors that we consider relevant. As part of our investigation of the business opportunity, we expect to meet personally with management and key personnel. To the extent possible, we intend to utilize written reports and personal investigation to evaluate the above factors.

We will not acquire or merge with any company for which audited financial statements cannot be obtained within a reasonable period of time after closing of the proposed transaction.

RESULTS OF OPERATIONS

THREE MONTHS ENDED ~~SEPTEMBER~~MARCH 3031, ~~2022~~2023 COMPARED TO THE THREE MONTHS ENDED ~~SEPTEMBER~~MARCH 3031, ~~2021~~2022

Revenue

We recognized no revenue during the three months period ended ~~September~~March 3031, ~~2022~~2023 or ~~2021~~2022 as we had no revenue generating activities during this period.

General and Administrative Expenses

During the three-months period ended ~~September~~March 3031, ~~2022~~2023, we incurred general and administrative expenses of $2627,~~403~~279, comprising director’s fees of $1520,000, $85,~~745~~000 inpaid ~~mailing~~and ~~expenses~~$15,000 ~~for~~accrued, ~~shareholder~~accounting ~~communications~~fees of $5,000, ~~auditing~~Edgar filing fees of $1,~~500~~035, ~~and~~state filing fees of $1819,~~158~~ inshare ~~other~~transfer ~~expenses~~agent fees of $225 and FINRA fees of $200.

Table of Contents

By comparison, during the three-months period ended ~~September~~March 3031, ~~2021~~2022, we incurred general and administrative expenses of $2817,~~966~~447, ~~comprising director’s fees of~~ $15,000, ~~$3,000~~ in ~~accounting~~accrued director fees, $1,~~583~~167 in OTC market fees, $1818 in Broadridge fees,~~533~~ $362 in Edgar filing fees and $~~350~~100 in ~~other~~ ~~expenses~~share transfer agent fees.

Operating loss

During the three-months periods ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022 we incurred operating losses of $2627,~~403~~279 and $2817,~~966~~447, respectively, due to to the factors described above.

Other income expense

During the three-~~month~~months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, we recognized no other income (expense).

Loss before Income Tax

During the three-months periods ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, we recognized losses before income taxes of $2627,~~403~~279 and $2817,~~966~~447, respectively, due to the factors discussed above.

Provision for Income Tax

No provision for income taxes was recorded during the three ~~month~~months periods ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022 as we incurred taxable losses in ~~both~~ both periods.

Net Loss

During the three-months periods ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, we recognized net losses of $2627,~~403~~279 and $2817,~~966~~447, respectively, due to the factors discussed above.

NINE MONTHS ENDED SEPTEMBER 30, 2022 COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2021

Revenue

We recognized no revenue during the nine months period ended September 30, 2022 or 2021 as we had no revenue generating activities during this period.

General and Administrative Expenses

During the nine-months period ended September 30, 2022, we incurred general and administrative expenses of $68,877, comprising director’s fees of $45,000, auditing fees of $10,000, $8,745 in mailing expenses for shareholder communications, a Edgar filing fees of $2,729, OTC Market fees of $1,167, Broadridge fees of $818, a payment to a former director of $500, share transfer agent fees of $475 and $443 in other expenses.

By comparison, during the nine-months period ended September 30, 2021we incurred general and administrative expenses of $90,066, comprising consulting fees to our pervious and current controlling shareholders of $74,900, professional fees of $10,500, various OTC, FINRA, Edgar and state filing fees of $4,216 and share transfer agent fees of $450. Of the consulting fees to our pervious and current controlling shareholders, $39,900 was attributable to the fair value of one share of Series A preferred stock issued to our current controlling shareholder.

Gain on Partial Settlement of Liabilities

We recognized no gain on a partial payment made to one of our creditors during the nine months ended September 30, 2022.

During the nine months ended September 30, 2021, we recognized a gain of $4,270 on a partial payment made to one of our creditors. The creditor reduced the remaining balance owed by us on receipt of the partial payment.

Table of Contents

Operating Loss

During the nine-months periods ended September 30, 2022 and 2021, we recognized operating losses of $69,877 and $85,796, respectively, due to the factors discussed above.

Other income (expense)

During the nine-month periods ended September 30, 2022 and 2021, we incurred no other income (expense).

Loss before Income Tax

During the nine-month periods ended September 30, 2022 and 2021, we recognized losses before income taxes of $69,877 and $85,796, respectively, due to the factors discussed above.

Provision for Income Tax

No provision for income taxes was recorded during the nine-month periods ended September 30, 2022 and 2021 as we incurred taxable losses in both periods.

Net Loss

During the nine-month periods ended September 30, 2022 and 2021, we recognized net losses of $69,877 and $85,796, respectively, due to the factors discussed above.

CASH FLOW

As of ~~September~~March 3031, ~~2022~~2023, we did not have any ~~cash~~ cash or cash equivalents, no assets, no revenue generating activities or other source of income and we had outstanding liabilities of of $~~222~~275,~~450~~161 and a shareholders’ deficit of $~~222~~275,~~450~~161.

By comparison, as of December 31, ~~2021~~2022, we did not have any cash or cash equivalents, ~~$1,167~~no ~~in prepaid~~ assets, no revenue generating activities or other source of income and we had outstanding liabilities of $~~153~~247,~~739~~882 and a shareholders’ deficit of $~~152~~247,~~572~~882.

Consequently, we are now dependent on raising additional equity and/or debt to meet our ongoing operating expenses. There is no assurance that we will be able to raise the necessary equity and/or debt that we will need to fund our ongoing operating expenses.

It is our current intention is to obtain debt or equity finance to meet our ongoing operating expenses and attempt to relist our shares of common stock on the Pink Sheets and then merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that any of the events can be successfully completed, that our shares of common stock will be relisted on the Pink Sheets, any such business will be identified or that any stockholder will realize any return on their shares after such a transaction has been completed. In particular, there is no assurance that any such business will be located or that any stockholder will realize any return on their shares after such a transaction. Any merger or acquisition completed by us can be expected to have a significant dilutive effect on the percentage of shares held by our current stockholders

Future losses are likely to occur as, until we are able to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders, we have no sources of income to meet our operating expenses. As a result of these, among other factors, we received from our registered independent public accountants in their report for the financial statements for the years ended December ~~31, 2021 and 2020, an explanatory paragraph stating that there is substantial doubt about our ability to continue as a going concern.~~

1716

Table of Contents

~~The following is a~~31, ~~summary~~2022, ofan ~~the~~explanatory ~~Company’s~~paragraph ~~cash~~stating ~~flows~~that ~~provided~~there byis ~~(used~~substantial ~~in)~~doubt ~~operating,~~about ~~investing,~~our ~~and~~ability ~~financing~~to ~~activities~~continue ~~for~~as ~~the~~a ~~three-month periods~~going ~~ended September 30, 2022 and 2021:~~ concern.

	Nine Months Ended September 30, 2022			Nine Months Ended September 30, 2021
Net Cash Used in Operating Activities	$	(22,670	)	$	(28,133	)
Net Cash Used in Investing Activities		—			—
Net Cash Provided by Financing Activities		22,670			28,133
Net Change in Cash	$	—		$	—

The following is a summary of the Company’s cash flows provided by (used in) operating, investing, and financing activities for the three-month periods ended March 31, 2023 and 2022:

	Three Months Ended March 31, 2023			Three Months Ended March 31, 2022
Net Cash Used in Operating Activities	$	(13,954	)	$	(1,180	)
Net Cash Used in Investing Activities		—			—
Net Cash Provided by Financing Activities		13,954			1,180
Net Change in Cash	$	—		$	—

Operating Activities

During the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023, we recognized a net loss $6927,~~877~~279 which was ~~reduced~~increased for cash flow purposes by a $1,~~167~~675 decrease in ~~prepaid~~accounts ~~expenses,~~payable aand $1accruals,~~040~~ ~~increase~~partially inoffset ~~accounts~~by ~~payable and~~ a $4515,000 ~~increase~~ increase in ~~accrued liabilities~~ accruals– related parties resulting in a net cash of $2213,~~670~~954 ~~cash~~ being used in operating activities.

By comparison, during ~~nine~~the three-months period ended ~~September~~March 3031, ~~2021~~2022, we recognized a net loss $8517,~~796~~447 which was reduced for cash flow purposes by ~~$39,900 for compensation paid in preferred stock and increased for cash flow purposes by~~ a $41,~~270~~167 ~~non-cash~~decrease ~~gain on the partial settlement of a liability and further increased for a $2,917 increase~~ in prepaid expenses, ~~and a~~ $~~2,050~~100 ~~reduction~~increase in accounts payable ~~expenses~~ and ~~decreased~~accrued byexpenses and a $2715,000 increase in ~~accrued~~ ~~liabilities~~ accruals– related parties resulting in a net cash of $281,~~133~~180 being used in operating activities.

Investing Activities

We did not engage in any investing activities during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022.

Financing Activities

During the ~~nine~~three-months period ended ~~September~~March 3031, ~~2022~~2023, we received $2213,~~670~~954 by way of loan from our chief financial officer, director and new controlling shareholder resulting in a total of $2213,~~670~~954 being generated from financing operations.

By comparison, during the ~~nine~~three-months period ended ~~September~~March 3031, ~~2021~~2022, we received $281,~~133~~180 by way of loan from our chief financial officer, director and new controlling shareholder resulting in a total of $281,~~133~~180 being generated from financing operations

We are dependent upon the receipt of capital investment or other financing to fund our ongoing operations and to execute our business plan to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. In addition, we are dependent upon our controlling shareholder to provide continued funding and capital resources. If continued funding and capital resources are unavailable at reasonable terms, we may not be able to implement our plan of operations

CRITICAL ACCOUNTING POLICIES

All companies are required to include a discussion of critical accounting policies and estimates used in the preparation of their financial statements. On an on-going basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Our significant accounting policies are described in Note 3 of our Condensed Unaudited Financial Statements above. These policies were selected because they represent the more significant accounting policies and methods that are broadly applied in the preparation of our financial statements.17

Table of Contents

Inflation

To date inflation has not been a major factor in our proposed business plan. However, there are significant inflationary pressures in the larger economy. The impact of inflation is being reflected in higher wages, increased pricing of equipment and products and generally higher prices across all sectors of the economy. We plan on carefully evaluating the impact of inflation and price increase pressures on our proposed business plan.

Off-Balance Sheet Arrangements

Per SEC regulations, we are required to disclose our off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, such as changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of ~~September~~March 3031, 2023 and December 31, 2022, we ~~have~~had no off-balance sheet arrangements.

Share-based Compensation

The cost of equity instruments issued to non-employees in return for goods and services is measured by the fair value of the equity instruments issued in accordance with ASC 718, “Compensation - Stock Compensation.” Measurement date for non-employees is the grant date of the stock-based compensation. The cost of employee services received in exchange for equity instruments is based on the grant date fair value of the equity instruments issued.

Recently Issued Accounting Pronouncements

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on our financial statements.

Contractual Obligations

None.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management conducted an evaluation, with the participation of our Chief Executive Officer, who is our principal executive officer, and our Chief Financial Officer, who is our principal financial and accounting officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this registration statement on Form 10. Based on that evaluation, we concluded that because of the material weakness and significant deficiencies in our internal control over financial reporting described below, our disclosure controls and procedures were not effective as of ~~September~~March 3031, ~~2022~~2023.

Management’s Annual Report on Internal Control over Financial Reporting

Management is responsible for the preparation of our financial statements and related information. Management uses its best judgment to ensure that the financial statements present accurately, in material respects, our financial position and results of operations in fairness and conformity with generally accepted accounting principles.

Table of Contents

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in the Exchange Act. These internal controls are designed to provide reasonable assurance that the reported financial information is presented fairly, that disclosures are adequate, and that the assumptions and opinions in the preparation of financial statements are reasonable. There are inherent limitations in the effectiveness of any system of internal controls, including the possibility of human error and overriding of controls. Consequently, an ineffective internal control system can only provide reasonable, not absolute, assurance with respect to reporting financial information.

Our internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that, in reasonable detail, accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles and that the receipts and expenditures of company assets are made in accordance with our management’s and directors’ authorization; and (iii) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could have a material effect on our financial statements.

We conducted an evaluation of the effectiveness of our internal control over financial reporting, based on the framework in “Internal Control Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and published in 2013, and subsequent guidance prepared by COSO specifically for smaller public companies. Based on that evaluation, management concluded that our internal control over financial reporting was not effective as of ~~September 30,~~March ~~2022~~31, 2023 for the reasons discussed below.

A significant deficiency is a deficiency, or combination of deficiencies in internal control over financial reporting, that adversely affects the entity’s ability to initiate, authorize, record, process, or report financial data reliably in accordance with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of the entity’s financial statements that is more than inconsequential will not be prevented or detected by the entity’s internal control. A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Management identified the following material weakness and significant deficiencies in its assessment of the effectiveness of internal control over financial reporting as of ~~September~~March 3031, ~~2022~~2023:

	●	Lack of a functioning audit committee and lack of a majority of outside directors on our board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures;
	●	Inadequate segregation of duties consistent with control objectives;
	●	Insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and
	●	Ineffective controls over period end financial disclosure and reporting processes.

There are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements. Our management does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and maintained, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must account for resource constraints. In addition, the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, can and will be detected.

This Form 10-Q does not include an attestation report from our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Commission that permit us to provide only management’s report in this Form 10-Q.

2019

Table of Contents

Changes in Internal Controls over Financial Reporting

There have been no changes in our internal control over financial reporting during the three-~~month~~months period ended ~~September~~March 3031, ~~2022~~2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

Item 1. Legal Proceedings.

There are presently no material pending legal proceedings to which the Company, any executive officer, any owner of record or beneficially of more than five percent of any class of voting securities is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

Item 1A. Risk Factors.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable to our Company.

Item 5. Other Information.

None.

Item 6. Exhibits.

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a–14(a) or 15d-14(a) of the Securities Exchange Act of 1934
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as an Inline XBRL document and included in Exhibit 101)

2120

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: October 28, 2022	SAXON CAPITAL GROUP, INC.
Date: May 15, 2023	SAXON CAPITAL GROUP, INC.
	/s/ Redgie Green
	Redgie Green
	Director and CEO
	(Chief Executive Officer and Principal Executive Officer)
	/s/ David Cutler
	David Cutler
	Director and CFO
	(Chief Financial Officer and Principal Accounting Officer)

2221

Filing Compare · Saxon Capital Group, Inc./DE